Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Journey
Companies On The Road
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Journey
Companies On The Road
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
Nice Insight Reports
2022 Sterile
2023 Cell & Gene Therapy
2023 mAb and Recombinant Protein
2024 API
2024 OSD
2024 ADC
2024 mRNA
2024 Mammalian Cell Culture
2024 Microbial Cell Culture
2024 Plasmids
2024 Gene Therapy
2024 Cell Therapy
2024 Sterile
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Sanofi (2)
51 Articles Available
2
3
Can't find what you're looking for? Try our
advanced search
.
Drug Development
EMA Recommends Approval of the First Oral Drug for Sleeping Sickness
PAO-M11-18-NI-019
Collaboration
Sanofi and Denali Therapeutics Enter New Collaboration
PAO-M11-18-NI-008
Vaccine
Positive Opinion Announced in EU for New Dengue Fever Vaccine
PAO-M10-18-NI-025
Approval
FDA approves Libtayo® (cemiplimab-rwlc) as first and only treatment for advanced cutaneous squamous cell carcinoma
PR-M10-18-NI-020
Market Expansion
Sanofi to further accelerate its scientific presence with the opening of a Global R&D Operations Hub in Chengdu, China
PR-M07-18-NI-017
Acquisition
Sanofi completes its acquisition of Ablynx following the expiration of the Squeeze-out Procedure
PR-M06-18-NI-074
Acquisition
Recipharm expands inhalation capabilities with GBP 45 million acquisition of Sanofi CMO business located in UK
PR-M06-18-NI-061
Extension Agreement
Beactica Signs Three-Year Extension Agreement With Sanofi
PR-M05-18-NI-114
Collaboration
Adaptive Biotechnologies Announces a Collaboration with Sanofi
PR-M05-18-NI-112
Clinical Trial
Sanofi: Accelerating Future Breakthroughs Through Clinical Trials -- Part 2 of 3
PR-M05-18-NI-080
Clinical Data
Regeneron and Sanofi Share First Positive Clinical Data for Cemiplimab in Advanced Non-small Cell Lung Cancer at ASCO
PR-M05-18-NI-075
Cell and Gene Therapy
Bioverativ and Sangamo Announce FDA Acceptance of IND Application for Gene-Edited Cell Therapy BIVV003 to Treat Sickle Cell Disease
PR-M05-18-NI-074
Announcement
Sanofi Named to DiversityInc's Top 50 Companies for Diversity®
PR-M05-18-NI-031
Diabetes
Sanofi’s Sotagliflozin Accepted for Review by EMA
PAO-M04-18-NI-006
FDA
FDA approves Toujeo® Max SoloStar®
PR-M03-18-NI-101
Innovation
Evotec and Sanofi in Exclusive Talks to Create an Evotec-Led Infectious Disease Open Innovation R&D Platform
PR-M03-18-NI-047
Licensing
Oxford BioMedica Completes Licensing Agreement with Bioverativ Inc.
PAO-M02-18-NI-019
Acquistion
Partner Therapeutics (PTx) Acquires Leukine® from Sanofi
PR-M02-18-NI-021
Acquistion
Sanofi Will Acquire Ablynx for €3.9 Billion
PAO-M01-18-NI-045
Acquisition
Sanofi Buys Bioverativ
PAO-M01-18-NI-036
Capacity Expansion
Sanofi Expanding Manufacturing Capacity for Quadrivalent Influenza Vaccine
PAO-M10-17-NI-043
Innovation
Potential Breakthrough HIV/AIDS Intervention Developed
PAO-M09-17-NI-035
Acquistion
Protein Sciences Officially Part of Sanofi
PAO-M09-17-NI-008
Acquisition
Emergent BioSolutions Expands Its Drug Portfolio Through Two Acquisitions
PAO-M07-17-NI-030
«
2
3
»